The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes ...
18h
24/7 Wall St. on MSNThese 10 Stocks Have Increased Dividends For Over 60 Consecutive Years. Should You Buy Them Now?Dividend King stocks can succumb to management complacency or over conservative policies that can dull a competitive edge, ...
Dow and X-Energy Reactor Company, LLC ("X-energy") announced the submission of a construction permit application to the Nuclear Regulatory Commission ("NRC") for a proposed advanced nuclear project in ...
Beacon Hill Roll Call records local senator’s votes on roll calls from recent Senate debate on a fiscal 2025 supplemental ...
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to ...
Real-time index price for TSX Comp Carbon Price Risk 2030 Adj Index (XECP), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
The acquisition is supported by 65 Equity Partners, a global investment firm dedicated to supporting family-owned businesses, founders, and entrepreneurs. As part of the transaction, 65 Equity ...
Canadian Solar faces challenges adapting to new technologies like TOPCon, incurring significant costs to update outdated ...
Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...
Trump's federal funding cuts are shutting down studies on Alzheimer’s care, uterine fibroids and pregnancy risks — all ...
The U.S. Food and Drug Administration (FDA) informed the company that an expanded access protocol for NVG-291 may proceed This news release constitutes a "designated news release" for the purposes of ...
The Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results